Patients live longer if they do not take antibiotics in month before immunotherapy
Taking antibiotics in the month before starting immunotherapy dramatically reduces a cancer patient’s chances of survival, according to a small but groundbreaking study.
Scientists at Imperial College London believe antibiotics strip out helpful bacteria from the gut, which weakens the immune system. This appears to make it less likely that immunotherapy drugs will boost the body’s cancer-fighting capability.
In their study of nearly 200 cancer patients in two NHS hospitals, the researchers found that those who had taken broad-spectrum antibiotics for just a few days for common problems such as chest infections survived for a median of two months after immunotherapy, compared with 26 months for those who had not been on antibiotics.
The substantial difference in survival, and clear evidence from CT scans that tumours grow more rapidly in those who have taken antibiotics, has led the researchers to call for more work to be done urgently to guide doctors.
“Antibiotics clearly wipe out some of the gut microbiota,” said Dr David Pinato, from ICL’s department of surgery and cancer, who was one of the authors of the study published in the journal Jama Oncology. “If you have got a good microbiome, you are more likely to have educated your immune system to fight cancer better.”
The results were the same no matter which antibiotics people were on or the type of cancer they had. In lung cancer, where chest infections are more common, median survival was 2.5 months in those who had been on antibiotics before starting the immunotherapy drugs, known as checkpoint inhibitors, versus 26 months in those who had not. In melanoma it was 3.9 versus 14 months, and in other tumours five weeks versus 11 months.
Full article link :-